CV Lattes
ORCID
Google Scholar Citations
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USP (HCMRP). Hemocentro de Ribeirão Preto (Institutional affiliation from the last research proposal) Birthplace: Brazil
Degree in Biological Sciences from the Methodist University of Piracicaba (2016). Master's degree (2019) in Pharmacology at the University of São Paulo at Ribeirão Preto Medical School. Started his PhD (2019) in Pharmacology at the University of São Paulo at Ribeirão Preto Medical School, where he investigates the mechanisms involved in the maintenance of neuropathic pain. He has been on the editorial board of DOL (Dor On-Line) since 2017, where he publishes recent scientific findings related to pain in a publicly accessible manner. Has experiences in Pharmacology and Physiology. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Bone marrow failure syndromes are a group of heterogeneous diseases that are characterized by the failure of hematopoietic stem and progenitor cells (HSCs), which can be caused by multiple factors that cause a reduction in HSCs, several factors can lead to such a reduction, among them the immune attack through cytotoxic T cells that attack HSCs and induce apoptosis. This attack is respons…
Pain is understood as a response generated after the recognition of a noxious stimulus and may be associated with an actual or potential injury. However, inflammatory processes and lesions in the somatosensory system can leads to understood pain as pathology. The perception of both nociceptive and pathological pain depends on the recognition of noxious stimuli by nociceptive sensory neuro…
In acquired immune aplastic anemia (immune AA), cytotoxic Th1 cells release cytokines that trigger changes in cell cycle and cell transcription, leading to HSC apoptosis, causing hematopoietic failure. Current treatments are limited and are hampered by the lack of compatible donors and complications. The current standard treatment is related-matched allogeneic hematopoietic stem cell tran…
| 1 / 1 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |